Atrys Health, S.A. (BME:ATRY)
Spain · Delayed Price · Currency is EUR 2.370
-0.045 (-1.86%)
Jul 17, 2026, 5:35 PM CET
Atrys Health Market Cap
Atrys Health has a market cap or net worth of €179.9 million as of July 17, 2026. Its market cap has decreased by -19.40% in one year.
Market Cap
179.90M
Enterprise Value
424.28M
Revenue
144.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.37
ChartMarket Cap Chart
Since July 22, 2016, Atrys Health's market cap has increased from 17.85M to 179.90M, an increase of 908.11%. That is a compound annual growth rate of 26.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 179.90M | -19.08% |
| Dec 31, 2025 | 222.31M | -13.13% |
| Dec 31, 2024 | 255.91M | -8.07% |
| Dec 29, 2023 | 278.37M | -39.03% |
| Dec 30, 2022 | 456.55M | -26.48% |
| Dec 30, 2021 | 620.95M | 107.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.49B |
| Laboratorios Farmaceuticos Rovi | 2.75B |
| Almirall | 2.32B |
| Faes Farma | 1.37B |
| Clínica Baviera | 935.48M |
| Oryzon Genomics | 237.84M |
| Prim, S.A. | 224.58M |
| Laboratorio Reig Jofre | 213.30M |